Works matching IS 17762596 AND DT 2022 AND VI 17 AND IP 2

Results: 10

Correction to: Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.

Published in:

2022

By:

Patnaik, Amita;
Gadgeel, Shirish;
Papadopoulos, Kyriakos P.;
Rasco, Drew W.;
Haas, Naomi B.;
Der-Torossian, Hirak;
Faltaos, Demiana;
Potvin, Diane;
Tassell, Vanessa;
Tawashi, Manal;
Chao, Richard;
O'Dwyer, Peter J.

Publication type:

Correction Notice

Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.

Published in:

Targeted Oncology, 2022, v. 17, n. 2, p. 125, doi. 10.1007/s11523-022-00875-0

By:

Patnaik, Amita;
Gadgeel, Shirish;
Papadopoulos, Kyriakos P.;
Rasco, Drew W.;
Haas, Naomi B.;
Der-Torossian, Hirak;
Faltaos, Demiana;
Potvin, Diane;
Tassell, Vanessa;
Tawashi, Manal;
Chao, Richard;
O'Dwyer, Peter J.

Publication type:

Article

Impact of Dose Intensity on Pathologic Complete Response Rate in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab and Pertuzumab (TCHP).

Published in:

Targeted Oncology, 2022, v. 17, n. 2, p. 167, doi. 10.1007/s11523-022-00874-1

By:

Le, Dat;
Vargo, Craig;
Collins, Stephanie;
Williams, Nicole;
Palettas, Marilly;
Berger, Michael

Publication type:

Article

Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers.

Published in:

Targeted Oncology, 2022, v. 17, n. 2, p. 177, doi. 10.1007/s11523-022-00871-4

By:

Takeda, Hiroyuki;
Imoto, Kiyomi;
Umemoto, Kumiko;
Doi, Ayako;
Arai, Hiroyuki;
Horie, Yoshiki;
Mizukami, Takuro;
Oguri, Tomoyo;
Ogura, Takashi;
Izawa, Naoki;
Yamamoto, Hiroyuki;
Yamano, Yoshihisa;
Sunakawa, Yu

Publication type:

Article

Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer.

Published in:

Targeted Oncology, 2022, v. 17, n. 2, p. 111, doi. 10.1007/s11523-022-00870-5

By:

Fan, Ping;
Jordan, V. Craig

Publication type:

Article

The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours.

Published in:

Targeted Oncology, 2022, v. 17, n. 2, p. 95, doi. 10.1007/s11523-022-00869-y

By:

Foo, Tiffany;
Goldstein, David;
Segelov, Eva;
Shapiro, Jeremy;
Pavlakis, Nick;
Desai, Jayesh;
Yip, Desmond;
Zalcberg, John;
Price, Timothy J.;
Nagrial, Adnan;
Chantrill, Lorraine;
Burge, Matt;
Karapetis, Christos S.;
Tebbutt, Niall;
Roy, Amitesh C.

Publication type:

Article

Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis.

Published in:

Targeted Oncology, 2022, v. 17, n. 2, p. 153, doi. 10.1007/s11523-022-00868-z

By:

Van Sanden, Suzy;
Murton, Molly;
Bobrowska, Anna;
Rahhali, Nora;
Sermon, Jan;
Rodrigues, Bernardo;
Goff-Leggett, Danielle;
Chouaid, Christos;
Sebastian, Martin;
Greystoke, Alastair

Publication type:

Article

Pembrolizumab in Combination with Chemotherapy in Patients with ERBB2-Mutated Non-Small Cell Lung Cancer.

Published in:

Targeted Oncology, 2022, v. 17, n. 2, p. 187, doi. 10.1007/s11523-022-00873-2

By:

Abu Rous, Fawzi;
Gutta, Radhika;
Li, Pin;
Halmos, Balazs;
Gadgeel, Shirish

Publication type:

Article

Cabozantinib plus Nivolumab: A Review in Advanced Renal Cell Carcinoma.

Published in:

Targeted Oncology, 2022, v. 17, n. 2, p. 193, doi. 10.1007/s11523-022-00866-1

By:

Markham, Anthony

Publication type:

Article

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.

Published in:

Targeted Oncology, 2022, v. 17, n. 2, p. 141, doi. 10.1007/s11523-022-00867-0

By:

Lee, Matilda Xinwei;
Wong, Andrea L. A.;
Ow, Samuel;
Sundar, Raghav;
Tan, David S. P.;
Soo, Ross A.;
Chee, Cheng Ean;
Lim, Joline S. J.;
Yong, Wei Peng;
Lim, Siew Eng;
Goh, Boon Cher;
Wang, Lingzhi;
Lee, Soo Chin

Publication type:

Article